Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...

Oral Drug Delivery Systems: Continuous-Release Systems

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pearls.

The Physician and sportsmedicine·2017

Same author

Pearls.

The Physician and sportsmedicine·2017

Same author

Attention deficit hyperactivity disorder and athletes.

Sports health·2014

Same author

Diabetes in the competitive athlete.

Current sports medicine reports·2012

Same author

Patient empowerment and optimal glycemic control.

Current medical research and opinion·2012

Same author

Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine·2011

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Insulin pump therapy (continuous subcutaneous insulin infusion).

Russell D White¹

¹Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood, Kansas City, MO 64139, USA. Russell.White@tmcmed.org

|December 7, 2007

Summary

Continuous subcutaneous insulin infusion (CSII) offers better diabetes management with less severe hypoglycemia. Future implanted insulin pumps promise near-normal blood sugar control and prevention of long-term diabetes complications.

More Related Videos

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Experiment Videos

Last Updated: Jul 9, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Endocrinology
Metabolic Diseases
Biomedical Engineering

Background:

Continuous subcutaneous insulin infusion (CSII) is a key therapy for diabetes management.
CSII systems improve treatment target achievement and reduce severe hypoglycemia.
Patient preference favors CSII for its flexibility, convenience, and physiologic glycemic control.

Purpose of the Study:

To highlight the benefits of current continuous subcutaneous insulin infusion (CSII) systems.
To discuss the future of insulin delivery with closed-loop systems.
To emphasize the potential for near-normal glycemia and prevention of diabetes complications.

Main Methods:

Review of current literature on continuous subcutaneous insulin infusion (CSII) therapy.
Analysis of patient-reported outcomes and preferences for CSII.
Projection of future advancements in insulin pump technology and closed-loop systems.

Main Results:

CSII systems enable effective glycemic control with a reduced incidence of severe hypoglycemia.
Patients report high satisfaction with CSII due to improved flexibility and convenience.
Future implanted, closed-loop systems are expected to further enhance glycemic control.

Conclusions:

Continuous subcutaneous insulin infusion (CSII) represents a significant advancement in diabetes care.
Implanted, closed-loop insulin delivery systems hold promise for achieving near-normal glycemia.
These advanced systems are anticipated to significantly reduce long-term diabetes complications and severe hypoglycemia.